Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieping Chen

Showing results (41-50 of 304) with videos related to

Pageof 31
Sort By:
Immunity|April 23, 2011
Cell surface signaling molecules in the control of immune responses: a tide modelYuwen Zhu, Sheng Yao, Lieping Chen
Nature Reviews. Drug Discovery|February 2, 2013
Advances in targeting cell surface signalling molecules for immune modulationSheng Yao, Yuwen Zhu, Lieping Chen
Immunologic Research|October 20, 2005
The many sounds of T lymphocyte silenceIgnacio Melero, Ainhoa Arina, Lieping Chen
Immunologic Research|May 15, 2007
LIGHT-related molecular network in the regulation of innate and adaptive immunityYanhui Xu, Koji Tamada, Lieping Chen
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 2015
Mechanistic Assessment of PD-1H Coinhibitory Receptor-Induced T Cell Tolerance to Allogeneic AntigensDallas B Flies, Tomoe Higuchi, Lieping Chen
Experimental Hematology & Oncology|December 12, 2013
Cancer immunotherapy: are we there yet?Zihai Li, Lieping Chen, Mark P Rubinstein
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 25, 2022
Could Programmed Death-Ligand 1 Copy Number Alterations be a Predictive Biomarker for Immunotherapy Response?Gavitt A Woodard, Christina Cho, Lieping Chen
Molecular Biotechnology|July 10, 2002
Immunoglobulin fusion proteins as a tool for evaluation of T-cell costimulatory moleculesAndrei I Chapoval, Gefeng Zhu, Lieping Chen
Nature Reviews. Immunology|June 26, 2007
How Ebola and Marburg viruses battle the immune systemMansour Mohamadzadeh, Lieping Chen, Alan L Schmaljohn
Annual Review of Immunology|April 26, 2022
Resistance Mechanisms to Anti-PD Cancer ImmunotherapyMatthew D Vesely, Tianxiang Zhang, Lieping Chen
Pageof 31

Showing results (41-50 of 304) with videos related to

Sort By:
Pageof 31
Immunity|April 23, 2011
Cell surface signaling molecules in the control of immune responses: a tide modelYuwen Zhu, Sheng Yao, Lieping Chen
Nature Reviews. Drug Discovery|February 2, 2013
Advances in targeting cell surface signalling molecules for immune modulationSheng Yao, Yuwen Zhu, Lieping Chen
Immunologic Research|October 20, 2005
The many sounds of T lymphocyte silenceIgnacio Melero, Ainhoa Arina, Lieping Chen
Immunologic Research|May 15, 2007
LIGHT-related molecular network in the regulation of innate and adaptive immunityYanhui Xu, Koji Tamada, Lieping Chen
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 2015
Mechanistic Assessment of PD-1H Coinhibitory Receptor-Induced T Cell Tolerance to Allogeneic AntigensDallas B Flies, Tomoe Higuchi, Lieping Chen
Experimental Hematology & Oncology|December 12, 2013
Cancer immunotherapy: are we there yet?Zihai Li, Lieping Chen, Mark P Rubinstein
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 25, 2022
Could Programmed Death-Ligand 1 Copy Number Alterations be a Predictive Biomarker for Immunotherapy Response?Gavitt A Woodard, Christina Cho, Lieping Chen
Molecular Biotechnology|July 10, 2002
Immunoglobulin fusion proteins as a tool for evaluation of T-cell costimulatory moleculesAndrei I Chapoval, Gefeng Zhu, Lieping Chen
Nature Reviews. Immunology|June 26, 2007
How Ebola and Marburg viruses battle the immune systemMansour Mohamadzadeh, Lieping Chen, Alan L Schmaljohn
Annual Review of Immunology|April 26, 2022
Resistance Mechanisms to Anti-PD Cancer ImmunotherapyMatthew D Vesely, Tianxiang Zhang, Lieping Chen
Pageof 31